Stability of Formulation Solutions on Various AAV Serotypes

Time: 2:10 pm
day: Track C - Day 2 PM

Details:

  • Formulation challenges in the context of Gtx drug development
  • Stability Variations in different AAV serotypes
  • Formulation feedback from regulators

Speakers: